Join the Giant Cell Arteritis group to help and get support from people like you.
Giant Cell Arteritis News
Doppler Ultrasound Feasible for First-Line Diagnosis of Giant Cell Arteritis
MONDAY, May 6, 2024 – For patients with high clinical suspicion of giant cell arteritis (GCA), color Doppler ultrasound of the temporal artery as a first-line diagnostic tool can avoid the need for...
FDA Approves Tyenne (tocilizumab-aazg), a Biosimilar to Actemra
March 7, 2024 – Fresenius Kabi, a global health care company that specializes in biopharmaceuticals, clinical nutrition, medical technologies, and I.V. generic drugs for critical and chronic...
Total Vascular Score From PET Scans Prognostic in Giant Cell Arteritis
TUESDAY, Oct. 3, 2023 – For patients with giant cell arteritis (GCA), a higher total vascular score (TVS) based on 18F-fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging at...
FDA Approves Actemra (tocilizumab) Subcutaneous Injection for Giant Cell Arteritis
May 22, 2017 – The U.S. Food and Drug Administration today expanded the approved use of subcutaneous Actemra (tocilizumab) to treat adults with giant cell arteritis. This new indication provides the...
Ask a question
To post your own question to this support group, sign in or create an account.